Armata Pharmaceuticals (ARMP) EBIT Margin (2016 - 2020)
Quarterly results put EBIT Margin at 14806.45% for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was 17661.54% (changed N/A YoY), and the annual figure for FY2017 was 14048.7%, down 505716.0%.
Armata Pharmaceuticals has reported EBIT Margin over the past 6 years, most recently at 14806.45% for Q2 2020.
- EBIT Margin reached 14806.45% in Q2 2020 per ARMP's latest filing, down from 11825.0% in the prior quarter.
- Across five years, EBIT Margin topped out at 1963.16% in Q3 2017 and bottomed at 53927.27% in Q4 2016.
- Median EBIT Margin over the past 3 years was 11748.28% (2016), compared with a mean of 16465.83%.
- The largest annual shift saw EBIT Margin crashed -5163040bps in 2016 before it surged 4210227bps in 2017.
- Over 3 years, EBIT Margin stood at 53927.27% in 2016, then skyrocketed by 78bps to 11825.0% in 2017, then fell by -25bps to 14806.45% in 2020.
- Business Quant data shows EBIT Margin for ARMP at 14806.45% in Q2 2020, 11825.0% in Q4 2017, and 1963.16% in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 38.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 17.83% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 23.02% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |